News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
113,759 Results
Type
Article (12472)
Company Profile (62)
Press Release (101225)
Section
Business (30375)
Career Advice (643)
Deals (5005)
Drug Delivery (29)
Drug Development (16610)
Employer Resources (42)
FDA (2512)
Job Trends (3303)
News (54105)
Policy (4825)
Tag
Academia (798)
Alliances (9544)
Alzheimer's disease (306)
Approvals (2497)
Artificial intelligence (38)
Best Places to Work (3053)
Biotechnology (54)
Breast cancer (41)
Cancer (351)
Cardiovascular disease (36)
Career advice (542)
CAR-T (35)
Cell therapy (108)
Clinical research (12741)
Collaboration (175)
Compensation (46)
COVID-19 (535)
C-suite (30)
Cystic fibrosis (53)
Data (421)
Diabetes (43)
Diagnostics (1665)
Drug discovery (28)
Duchenne muscular dystrophy (26)
Earnings (9761)
Employer resources (43)
Events (15679)
Executive appointments (68)
FDA (2699)
Funding (106)
Gene editing (52)
Gene therapy (123)
GLP-1 (108)
Government (698)
Healthcare (3406)
Infectious disease (558)
Interviews (125)
IPO (2433)
Job creations (445)
Job search strategy (460)
Layoffs (69)
Legal (773)
Lung cancer (48)
Lymphoma (31)
Manufacturing (44)
Medical device (926)
Medtech (926)
Mergers & acquisitions (2648)
Metabolic disorders (106)
Neuroscience (413)
NextGen: Class of 2025 (1102)
Non-profit (977)
Northern California (438)
Obesity (65)
Opinion (70)
Parkinson's disease (36)
People (9129)
Phase I (4515)
Phase II (5712)
Phase III (4289)
Pipeline (138)
Postmarket research (331)
Preclinical (1995)
Radiopharmaceuticals (36)
Rare diseases (149)
Real estate (719)
Regulatory (3714)
Research institute (861)
Resumes & cover letters (84)
Southern California (336)
Startups (763)
United States (3449)
Vaccines (104)
Weight loss (31)
Date
Today (28)
Last 7 days (103)
Last 30 days (446)
Last 365 days (7647)
2025 (422)
2024 (7710)
2023 (7966)
2022 (11766)
2021 (12096)
2020 (10060)
2019 (8482)
2018 (6189)
2017 (6106)
2016 (5547)
2015 (6217)
2014 (4389)
2013 (3560)
2012 (3444)
2011 (3376)
2010 (2903)
Location
Africa (197)
Asia (6282)
Australia (1262)
California (925)
Canada (222)
China (83)
Connecticut (52)
Europe (18347)
Florida (117)
Illinois (65)
Indiana (76)
Japan (32)
Maryland (130)
Massachusetts (809)
Michigan (47)
New Jersey (208)
New York (244)
North Carolina (169)
Northern California (438)
Ohio (37)
Pennsylvania (247)
South America (240)
Southern California (336)
Texas (101)
Utah (50)
Washington State (100)
113,759 Results for "ares genetics gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH
January 14, 2025
·
3 min read
Business
OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven
OpGen, Inc. announced today that its subsidiary Ares Genetics GmbH (Ares Genetics) and the Belgian National Reference Centre have entered into a collaboration agreement to jointly evaluate computational tools developed by Ares Genetics for the identification and characterization of Streptococcus pneumoniae for diagnostic purposes.
July 26, 2022
·
6 min read
Deals
Great Point Partners Acquires Lyocontract GmbH, Germany-Based Drug Product CDMO
Great Point Partners, a Greenwich-based investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH, a premium independent drug product contract development and manufacturing organization based in Ilsenburg, Germany.
June 13, 2024
·
3 min read
Press Releases
Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH
November 25, 2024
·
4 min read
Business
Oakwood Chemical Announces Strategic Partnership with EMP Biotech GmbH
Oakwood Chemical is thrilled to unveil its collaboration with EMP Biotech GmbH, a move set to streamline the oligo synthesis supply chain.
April 9, 2024
·
2 min read
Approvals
ARS Pharma Gets FDA Green Light for First Nasal Spray for Severe Allergic Reactions
ARS Pharma’s neffy on Friday became the first FDA-approved nasal spray to address severe allergic reactions, including those that might lead to life-threatening anaphylaxis.
August 12, 2024
·
2 min read
·
Tristan Manalac
Press Releases
ARS Pharmaceuticals Announces Filings for Approval of neffy® in China, Japan and Australia
December 13, 2024
·
8 min read
Press Releases
FGK Clinical Research GmbH Highlights 3.5 Years of Success with Flex Databases
October 10, 2024
·
1 min read
Press Releases
InflaRx Announces First Patient Dosed in Phase 2a Study for Oral C5aR Inhibitor INF904
December 20, 2024
·
6 min read
Business
OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in Europe
OpGen, Inc. and OpGen subsidiary, Ares Genetics, which strives to become a leader in bacterial genomics and AI-powered prediction of antimicrobial resistance (AMR), announced today that one of its key patents under opposition has been successfully maintained.
June 26, 2023
·
4 min read
1 of 11,376
Next
